Back
Security National Financial 10K Form
Buy
89
SNFCA
Security National Financial
Last Price:
10.48
Seasonality Move:
14.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-14 | 10Q | SNFCA/Security National Financial Quarterly |
| 2023-11-14 | 10Q | SNFCA/Security National Financial Quarterly |
| 2023-08-14 | 10Q | SNFCA/Security National Financial Quarterly |
| 2023-05-15 | 10Q | SNFCA/Security National Financial Quarterly |
| 2022-11-14 | 10Q | SNFCA/Security National Financial Quarterly |
| 2022-08-15 | 10Q | SNFCA/Security National Financial Quarterly |
Receive SNFCA News And Ratings
See the #1 stock for the next 7 days that we like better than SNFCA
SNFCA Financial Statistics
Sales & Book Value
| Annual Sales: | $318.52M |
|---|---|
| Cash Flow: | $-17.14M |
| Price / Cash Flow: | 4.34 |
| Annual Sales: | $12.82 |
| Price / Book: | 0.78 |
Profitability
| EPS (TTM): | 0.89520 |
|---|---|
| Net Income (TTM): | $21.65M |
| Gross Margin: | -- |
| Return on Equity: | 6.96% |
| Return on Assets: | 1.51% |
Security National Financial Earnings Forecast
Key Security National Financial Financial Ratios
- The Interest Expense is 33.57% of Operating Income.
- The Net Earning history of SNFCA is 4.55% of Total Revenues.
- Per Share Earnings over the last 38 years have been positive in 20 years.
Security National Financial Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Financial Services |
| Sector: | Financials |
| Current Symbol: | SNFCA |
| Website: | securitynational.com |
Debt
| Debt-to-Equity Ratio: | 0.32 |
|---|---|
| Current Ratio: | 13.02 |
| Quick Ratio: | 13.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.29 |
|---|---|
| Forward P/E Ratio: | 0 |
SNFCA Technical Analysis vs Fundamental Analysis
Buy
89
Security National Financial (SNFCA)
is a Buy
Is Security National Financial a Buy or a Sell?
-
Security National Financial stock is rated a Buy
The current Security National Financial [SNFCA] share price is $10.54. The Score for SNFCA is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.